Claudette Foreman

  • Citations Per Year
Learn More
Breast cancer patients who are taking adjuvant Aromatase Inhibitor (AI) therapy typically have extremely low estradiol levels, which are undetectable by routine clinical laboratories. Thus, it(More)
  • 1